Elekta Xoft®
Breast eBx
Broaden your breast cancer care offering
Elekta Xoft products may not be available in all markets.
Treat early-stage breast cancer at the time of surgery
Intra-Operative Radiation Therapy (IORT) using Elekta Xoft offers an effective alternative to traditional six-week postoperative radiation therapy for early-stage breast cancer.
For appropriately selected patients, Elekta Xoft allows you to deliver precise and immediate single-fraction radiation treatment during breast conserving surgery. It targets the prescribed radiation dose directly to the tumor bed, the area with the highest risk of recurrence, while sparing surrounding healthy tissue and organs.
Why Elekta Xoft for breast cancer treatment?
Treat with precision
Elekta Xoft applicators ensure a precise fit to the tumor cavity, delivering uniform dose distributions to the tumor bed immediately during surgery.
Support faster recovery
Single fraction radiation treatment during surgery supports a more rapid recovery and improved quality of life for patients.
Boost efficient workflows
Using a pre-sterilized, single-use applicator, Elekta Xoft integrates seamlessly into surgical workflows, enhancing efficiency and allowing you to treat more patients with ease.
Experience versatility
Elekta Xoft can be used to deliver IORT in a single fraction or boost dose, or for accelerated partial breast irradiation (APBI) following surgery, depending on specific patient needs.
Elekta Xoft gives you the flexibility to provide advanced breast cancer care where it’s needed
The use of low energy radiation eliminates the need for dedicated shielding, enabling treatment in standard operating theatres.
Compact and lightweight, the Elekta Xoft System can be transported easily across multiple treatment settings.
Disposable Elekta Xoft Balloon Applicator is available in multiple sizes to fit a variety of tumor cavity volumes.
Elekta Xoft FlexiShield and Elekta Xoft Rigid Shield provide additional protection for adjacent tissue or organs, if required.
Explore Elekta Xoft products for Breast eBx
"Our ongoing research with Elekta Xoft for early-stage breast cancer corroborates the mounting long-term evidence supporting 50 kV IORT as a treatment option that is as effective as weeks of daily radiation fractions. Xoft IORT can spare patients who are candidates from the need to make multiple trips to the hospital for treatment, with the added benefit of fewer side effects and comparable recurrence rates. It offers added convenience for women living in remote areas who must travel great distances for radiation."
A.M. Nisar Syed, MD
Radiation Oncology, Todd Cancer Institute
Memorial Care Long Beach Medical Center
Explore the evidence
A growing body of clinical evidence supports the use of electronic brachytherapy for the treatment of breast cancer
Explore